PKG-1α leucine zipper domain defect increases pulmonary vascular tone: Implications in hypoxic pulmonary hypertension

Ramaswamy Ramchandran, Aarti Raghavan, David Geenen, Miranda Sun, Laura Bach, Qiwei Yang, J. Usha Raj

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Pulmonary hypertension (PH) is a chronic disease characterized by a progressive increase in vasomotor tone, narrowing of the vasculature with structural remodeling, and increase in pulmonary vascular resistance. Current treatment strategies include nitric oxide therapy and methods to increase cGMP-mediated vasodilatation. cGMP-depen-dent protein kinases (PKG) are known mediators of nitric oxide- and cGMP-induced vasodilatation. Deletion of PKG-1 in mice has been shown to induce PH, however, the exact mechanisms by which loss of PKG-1 function leads to PH is not known. In a mouse model with a selective mutation in the NH2-terminus leucine zipper protein interaction domain of PKG-1a [leucine zipper mutant (LZM)], we found a progressive increase in right ventricular systolic pressure and right heart hypertrophy compared with wild-type (WT) mice and increased RhoA-GTPase activity in the lungs. When exposed to chronic hypoxia, LZM mice developed modestly enhanced right ventricular remodeling compared with WT mice. Tadalafil, a phosphodiesterase-5 inhibitor that increases cGMP levels, significantly attenuated hypoxia-induced cardiopulmonary remodeling in WT mice but had no effect in LZM mice. We conclude that a functional leucine zipper domain in PKG-1a is essential for maintenance of a low pulmonary vascular tone in normoxia and for cGMP-mediated beneficial effects of phosphodiesterase-5 inhibition in hypoxic cardiopulmonary remodeling.

Original languageEnglish (US)
Pages (from-to)L537-L544
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume307
Issue number7
DOIs
StatePublished - Oct 1 2014

Fingerprint

Leucine Zippers
Pulmonary Hypertension
Blood Vessels
Lung
Vasodilation
Nitric Oxide
Protein Interaction Domains and Motifs
Type 5 Cyclic Nucleotide Phosphodiesterases
Phosphodiesterase 5 Inhibitors
Ventricular Remodeling
GTP Phosphohydrolases
Cardiomegaly
Ventricular Pressure
Vascular Resistance
Protein Kinases
Chronic Disease
Maintenance
Blood Pressure
Mutation

Keywords

  • 5'-cyclic monophosphate-depen-dent protein kinase
  • Hypoxia
  • Leucine zipper mutant guanosine 3'
  • Phosphodiesterases
  • Pulmonary hypertension and right ventricular hypertrophy

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

PKG-1α leucine zipper domain defect increases pulmonary vascular tone : Implications in hypoxic pulmonary hypertension. / Ramchandran, Ramaswamy; Raghavan, Aarti; Geenen, David; Sun, Miranda; Bach, Laura; Yang, Qiwei; Usha Raj, J.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 307, No. 7, 01.10.2014, p. L537-L544.

Research output: Contribution to journalArticle

Ramchandran, Ramaswamy ; Raghavan, Aarti ; Geenen, David ; Sun, Miranda ; Bach, Laura ; Yang, Qiwei ; Usha Raj, J. / PKG-1α leucine zipper domain defect increases pulmonary vascular tone : Implications in hypoxic pulmonary hypertension. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2014 ; Vol. 307, No. 7. pp. L537-L544.
@article{db347b568eb2458a90987ff663ded3c4,
title = "PKG-1α leucine zipper domain defect increases pulmonary vascular tone: Implications in hypoxic pulmonary hypertension",
abstract = "Pulmonary hypertension (PH) is a chronic disease characterized by a progressive increase in vasomotor tone, narrowing of the vasculature with structural remodeling, and increase in pulmonary vascular resistance. Current treatment strategies include nitric oxide therapy and methods to increase cGMP-mediated vasodilatation. cGMP-depen-dent protein kinases (PKG) are known mediators of nitric oxide- and cGMP-induced vasodilatation. Deletion of PKG-1 in mice has been shown to induce PH, however, the exact mechanisms by which loss of PKG-1 function leads to PH is not known. In a mouse model with a selective mutation in the NH2-terminus leucine zipper protein interaction domain of PKG-1a [leucine zipper mutant (LZM)], we found a progressive increase in right ventricular systolic pressure and right heart hypertrophy compared with wild-type (WT) mice and increased RhoA-GTPase activity in the lungs. When exposed to chronic hypoxia, LZM mice developed modestly enhanced right ventricular remodeling compared with WT mice. Tadalafil, a phosphodiesterase-5 inhibitor that increases cGMP levels, significantly attenuated hypoxia-induced cardiopulmonary remodeling in WT mice but had no effect in LZM mice. We conclude that a functional leucine zipper domain in PKG-1a is essential for maintenance of a low pulmonary vascular tone in normoxia and for cGMP-mediated beneficial effects of phosphodiesterase-5 inhibition in hypoxic cardiopulmonary remodeling.",
keywords = "5'-cyclic monophosphate-depen-dent protein kinase, Hypoxia, Leucine zipper mutant guanosine 3', Phosphodiesterases, Pulmonary hypertension and right ventricular hypertrophy",
author = "Ramaswamy Ramchandran and Aarti Raghavan and David Geenen and Miranda Sun and Laura Bach and Qiwei Yang and {Usha Raj}, J.",
year = "2014",
month = "10",
day = "1",
doi = "10.1152/ajplung.00093.2014",
language = "English (US)",
volume = "307",
pages = "L537--L544",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "7",

}

TY - JOUR

T1 - PKG-1α leucine zipper domain defect increases pulmonary vascular tone

T2 - Implications in hypoxic pulmonary hypertension

AU - Ramchandran, Ramaswamy

AU - Raghavan, Aarti

AU - Geenen, David

AU - Sun, Miranda

AU - Bach, Laura

AU - Yang, Qiwei

AU - Usha Raj, J.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Pulmonary hypertension (PH) is a chronic disease characterized by a progressive increase in vasomotor tone, narrowing of the vasculature with structural remodeling, and increase in pulmonary vascular resistance. Current treatment strategies include nitric oxide therapy and methods to increase cGMP-mediated vasodilatation. cGMP-depen-dent protein kinases (PKG) are known mediators of nitric oxide- and cGMP-induced vasodilatation. Deletion of PKG-1 in mice has been shown to induce PH, however, the exact mechanisms by which loss of PKG-1 function leads to PH is not known. In a mouse model with a selective mutation in the NH2-terminus leucine zipper protein interaction domain of PKG-1a [leucine zipper mutant (LZM)], we found a progressive increase in right ventricular systolic pressure and right heart hypertrophy compared with wild-type (WT) mice and increased RhoA-GTPase activity in the lungs. When exposed to chronic hypoxia, LZM mice developed modestly enhanced right ventricular remodeling compared with WT mice. Tadalafil, a phosphodiesterase-5 inhibitor that increases cGMP levels, significantly attenuated hypoxia-induced cardiopulmonary remodeling in WT mice but had no effect in LZM mice. We conclude that a functional leucine zipper domain in PKG-1a is essential for maintenance of a low pulmonary vascular tone in normoxia and for cGMP-mediated beneficial effects of phosphodiesterase-5 inhibition in hypoxic cardiopulmonary remodeling.

AB - Pulmonary hypertension (PH) is a chronic disease characterized by a progressive increase in vasomotor tone, narrowing of the vasculature with structural remodeling, and increase in pulmonary vascular resistance. Current treatment strategies include nitric oxide therapy and methods to increase cGMP-mediated vasodilatation. cGMP-depen-dent protein kinases (PKG) are known mediators of nitric oxide- and cGMP-induced vasodilatation. Deletion of PKG-1 in mice has been shown to induce PH, however, the exact mechanisms by which loss of PKG-1 function leads to PH is not known. In a mouse model with a selective mutation in the NH2-terminus leucine zipper protein interaction domain of PKG-1a [leucine zipper mutant (LZM)], we found a progressive increase in right ventricular systolic pressure and right heart hypertrophy compared with wild-type (WT) mice and increased RhoA-GTPase activity in the lungs. When exposed to chronic hypoxia, LZM mice developed modestly enhanced right ventricular remodeling compared with WT mice. Tadalafil, a phosphodiesterase-5 inhibitor that increases cGMP levels, significantly attenuated hypoxia-induced cardiopulmonary remodeling in WT mice but had no effect in LZM mice. We conclude that a functional leucine zipper domain in PKG-1a is essential for maintenance of a low pulmonary vascular tone in normoxia and for cGMP-mediated beneficial effects of phosphodiesterase-5 inhibition in hypoxic cardiopulmonary remodeling.

KW - 5'-cyclic monophosphate-depen-dent protein kinase

KW - Hypoxia

KW - Leucine zipper mutant guanosine 3'

KW - Phosphodiesterases

KW - Pulmonary hypertension and right ventricular hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=84907494666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907494666&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00093.2014

DO - 10.1152/ajplung.00093.2014

M3 - Article

C2 - 25128522

AN - SCOPUS:84907494666

VL - 307

SP - L537-L544

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 7

ER -